Peter H. Hutson

7.6k total citations
133 papers, 6.3k citations indexed

About

Peter H. Hutson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Peter H. Hutson has authored 133 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Cellular and Molecular Neuroscience, 53 papers in Molecular Biology and 14 papers in Cognitive Neuroscience. Recurrent topics in Peter H. Hutson's work include Neurotransmitter Receptor Influence on Behavior (65 papers), Neuroscience and Neuropharmacology Research (61 papers) and Receptor Mechanisms and Signaling (40 papers). Peter H. Hutson is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (65 papers), Neuroscience and Neuropharmacology Research (61 papers) and Receptor Mechanisms and Signaling (40 papers). Peter H. Hutson collaborates with scholars based in United Kingdom, United States and Mexico. Peter H. Hutson's co-authors include G. Curzon, Colin T. Dourish, Fraser Murray, Linda J. Bristow, G. S. Sarna, David Smith, Mark D. Tricklebank, Thomas P. Donohoe, Marc N. Potenza and Joanne E. Hogg and has published in prestigious journals such as Journal of Neuroscience, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

Peter H. Hutson

129 papers receiving 6.0k citations

Peers

Countries citing papers authored by Peter H. Hutson

Since Specialization

Citations

This map shows the geographic impact of Peter H. Hutson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Hutson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Hutson more than expected).

Fields of papers citing papers by Peter H. Hutson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Hutson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Hutson. The network helps show where Peter H. Hutson may publish in the future.

Co-authorship network of co-authors of Peter H. Hutson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Hutson. A scholar is included among the top collaborators of Peter H. Hutson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Hutson. Peter H. Hutson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cotyledonoid dissecting leiomyoma: case report of a rare subtype 2023 ·Pathology ·(unknown), Peter H. Hutson	0
2	Binge-eating disorder: Clinical and therapeutic advances 2017 ·Pharmacology & Therapeutics ·Peter H. Hutson, Iris M. Balodis, Marc N. Potenza	40
3	The neurobiological basis of binge-eating disorder 2016 ·Neuroscience & Biobehavioral Reviews ·Robert Kessler, Peter H. Hutson, Barry K. Herman, Marc N. Potenza	244
4	Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: A novel d-amphetamine pro-drug 2014 ·Neuropharmacology ·Peter H. Hutson, Michael Pennick, (unknown)	56
5	The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4 H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Sean M. Smith, Jason M. Uslaner, Lihang Yao, Chadwick Mullins, (unknown), Sarah L. Huszar, Caitlyn McNaughton, Danette Pascarella, Monika Kandebo, (unknown), Tim Sparey, Nicholas J. Brandon, Brian V. Jones, Shankar Venkatraman, Mary Beth Young, Nancy A. Sachs, Marlene A. Jacobson, Peter H. Hutson	73
6	Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT1A or 5-HT2C/2B receptor antagonists 2007 ·European Journal of Pharmacology ·Fraser Murray, Peter H. Hutson	28
7	N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jason Elliott, Robert W. Carling, Gary G. Chicchi, James Crawforth, Peter H. Hutson, A. Brian Jones, Sarah Kelly, Rose Marwood, Georgina Meneses‐Lorente, (unknown), Fraser Murray, Michael Rigby, Inmaculada Royo, Michael G. N. Russell, Duncan Shaw, Bindi Sohal, (unknown), Brian J. Williams	15
8	Antidepressants and REM sleep in Wistar–Kyoto and Sprague–Dawley rats 2005 ·European Journal of Pharmacology ·Magnus Ivarsson, Louise M. Paterson, Peter H. Hutson	53
9	Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression 2005 ·Neuropharmacology ·Martin R. Guscott, Linda J. Bristow, Karen L. Hadingham, T.W. Rosahl, Margaret S. Beer, Josephine A. Stanton, Frances A. Bromidge, Andrew P. Owens, Ian T. Huscroft, (unknown), N.M.J. Rupniak, Shil Patel, Paul J. Whiting, Peter H. Hutson, K.C.F. Fone, Stephany M. Biello, Janusz J. Kulagowski, George McAllister	184
10	Anxiogenic properties of an inverse agonist selective for α3 subunit‐containing GABA_A receptors 2005 ·British Journal of Pharmacology ·John Atack, Peter H. Hutson, Neil Collinson, George Marshall, Graham Bentley, Christopher R. Moyes, Susan M. Cook, Ian Collins, Keith A. Wafford, Ruth M. McKernan, Gerard R. Dawson	116
11	Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. 2003 ·PubMed Central ·David S. Reynolds, Thomas W. Rosahl, Jennifer Cirone, Gillian F. O’Meara, (unknown), Richard J. Newman, (unknown), Cyrille Sur, Owain W. Howell, A. Richard Rutter, John Atack, Alison Macaulay, Karen L. Hadingham, Peter H. Hutson, Delia Belelli, Jeremy J. Lambert, Gerard R. Dawson, Ruth M. McKernan, Paul J. Whiting, Keith A. Wafford	240
12	Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist 2003 ·European Journal of Pharmacology ·Peter H. Hutson, Shil Patel, (unknown), Cheryl L. Barton	28
13	The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor 2003 ·Neuropharmacology ·Martin R. Guscott, (unknown), G.P. Cook, Josephine A. Stanton, Margaret S. Beer, T.W. Rosahl, Sabine Hartmann, Janusz J. Kulagowski, George McAllister, K.C.F. Fone, Peter H. Hutson	82
14	Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists: neurochemical and behavioural studies 2000 ·Neuropharmacology ·Peter H. Hutson, Cheryl L. Barton, (unknown), Peter Blurton, (unknown), R.B. Clarkson, Linda J. Bristow	59
15	Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: Evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors 1999 ·Synapse ·Cheryl L. Barton, Peter H. Hutson	37
16	Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes 1996 ·Neurochemical Research ·(unknown), Peter H. Hutson, James P. Sullivan, Susan Wonnacott	84
17	Generation and Characterisation of Stable Cell Lines Expressing Recombinant Human N‐Methyl‐d‐Aspartate Receptor Subtypes 1996 ·Journal of Neurochemistry ·Sarah Grimwood, B. Le Bourdellès, John Atack, Cheryl L. Barton, (unknown), Susan M. Cook, Elizabeth R. Gilbert, Peter H. Hutson, Ruth M. McKernan, (unknown), C I Ragan, Peter B. Wingrove, Paul J. Whiting	42
18	The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HTT concentration and behaviour in the guinea pig 1995 ·Neuropharmacology ·Peter H. Hutson, Linda J. Bristow, J.R. Cunningham, Joanne E. Hogg, J. Longmore, Fraser Murray, David Pearce, (unknown), Kay L. Saywell, Mark D. Tricklebank, Lisa Young	33
19	Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice 1994 ·European Journal of Pharmacology ·Linda J. Bristow, (unknown), Mark D. Tricklebank, Peter H. Hutson	22
20	Activation of postsynaptic striatal dopamine receptors, monitored by efflux of cAMP in vivo 1990 ·Neuropharmacology ·Peter H. Hutson, Nirmala Suman‐Chauhan	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact